Sigachi Industries Ltd.

₹20.25

-0.8 (-3.7%)

SIGACHI Share Price

Pharmaceuticals & Biotechnology

As on April 28, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 782 Cr

P/E Ratio11.12

Dividend Yield0.49 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	21.74	Bearish
10-DMA	22.36	Bearish
20-DMA	21.12	Bearish
50-DMA	20.65	Bearish
100-DMA	24.95	Bearish
200-DMA	31.01	Bearish

Historical Performance

1 Year

-53.2%

3 Years

-17.4%

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	4,882	3,990	3,020	2,503	1,928
Total Expenditure	3,883	3,223	2,433	1,972	1,540
Other Income	205	117	67	26	33
Operating Profit	1,205	883	654	557	420
Interest	124	78	43	12	12
Depreciation	158	108	66	29	23
Profit Before Tax	923	698	545	516	385
Consolidated Net Profit	696	572	435	400	303
Adjusted EPS	2	2	1	1	1

Compounded Sales Growth

10 Years:37.1

5 Years:28.6

3 Years:14.3

TTM:4.1

Compounded Profit Growth

10 Years:58.6

5 Years:27.9

3 Years:11.7

TTM:4

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:-6.2

TTM:-53.5

Return on Equity

10 Years:N/A

5 Years:1.3

3 Years:1.4

last year:1.8

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	382	328	307	307	77
Total Reserves	5,626	3,388	2,376	1,970	865
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	480	653	308	76	70
Other Current Liabilities	287	451	143	64	51
Short Term Borrowings	1,181	924	395	331	183
Total Liabilities	8,462	6,942	3,737	2,868	1,334
Capital Work in Progress	86	966	349	97	37
Long Term Loans & Advances	480	147	210	117	44
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	149	226	145	146	57
Total Current Assets	3,943	3,133	1,774	1,799	871
Total Assets	8,462	6,942	3,737	2,868	1,334
Adjusted Book Value	16	11	9	7	4

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a moderate PE of 11.12, suggesting fair valuation relative to earnings.
Over the last three years, the stock delivered a weak 3-year price CAGR of -6.5%, indicating poor shareholder returns.
The stock carries a high beta of 1.4, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹1205 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹4882 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 464982.8

No. of Shares: 22962 (Approx)

Performance:-53.5%

P/L: ₹-535017.2

NIFTY Performance: -1.4%

1 day Top Gainers